39 results on '"Alternative Splicing"'
Search Results
2. Association of polymorphisms in the haplotype block spanning the alternatively spliced exons of the NTNG1 gene at 1p13.3 with schizophrenia in Japanese populations
- Author
-
Ohtsuki, T., Horiuchi, Y., Koga, M., Ishiguro, H., Inada, T., Iwata, N., Ozaki, N., Ujike, H., Watanabe, Y., Someya, T., and Arinami, T.
- Subjects
- *
CHROMOSOMES , *SCHIZOPHRENIA , *SOCIAL groups - Abstract
Abstract: Chromosome 1p13 is linked with schizophrenia in Japanese families, and one of the candidate genes in this region is the netrin G1 (NTNG1) gene at 1p13.3. Associations of 56 tag single-nucleotide polymorphisms (SNPs) with schizophrenia were explored by transmission disequilibrium analysis in 160 Japanese trios and by case–control analysis in 2174 Japanese cases and 2054 Japanese controls. An association between SNP rs628117 and schizophrenia was identified by case–control comparison (nominal allelic p =0.0009; corrected p =0.006). The associated polymorphism is located in intron 9 and in the haplotype block encompassing the alternatively spliced exons of the gene. Allelic association of a different SNP in the same haplotype block in Japanese families was previously reported. These findings support that the NTNG1 gene is associated with schizophrenia in the Japanese. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
3. Intron retention as a new pre-symptomatic marker of aging and its recovery to the normal state by a traditional Japanese multi-herbal medicine.
- Author
-
Okada N, Oshima K, Iwasaki Y, Maruko A, Matsumura K, Iioka E, Vu TD, Fujitsuka N, Nishi A, Sugiyama A, Nishiyama M, Kaneko A, Mizoguchi K, Yamamoto M, and Nishimura S
- Subjects
- Aging drug effects, Alternative Splicing, Animals, Gene Expression Regulation drug effects, Heat-Shock Response, Introns, Japan, Klotho Proteins, Liver drug effects, Medicine, Traditional, Metabolomics, Mice, Models, Animal, Phytochemicals pharmacology, RNA Precursors genetics, Sequence Analysis, RNA, Aging genetics, Gene Expression Profiling methods, Genetic Markers drug effects, Glucuronidase genetics, Liver chemistry, Phytochemicals administration & dosage
- Abstract
Intron retention (IR) is an important regulatory mechanism that affects gene expression and protein functions. Using klotho mice at the pre-symptomatic state, we discovered that retained-introns accumulated in several organs including the liver and that among these retained introns in the liver a subset was recovered to the normal state by a Japanese traditional herbal medicine. This is the first report of IR recovery by a medicine. IR-recovered genes fell into two categories: those involved in liver-specific metabolism and in splicing. Metabolome analysis of the liver showed that the klotho mice were under starvation stress. In addition, our differentially expressed gene analysis showed that liver metabolism was actually recovered by the herbal medicine at the transcriptional level. By analogy with the widespread accumulation of intron-retained pre-mRNAs induced by heat shock stress, we propose a model in which retained-introns in klotho mice were induced by an aging stress and in which this medicine-related IR recovery is indicative of the actual recovery of liver-specific metabolic function to the healthy state. Accumulation of retained-introns was also observed at the pre-symptomatic state of aging in wild-type mice and may be an excellent marker for this state in general., (Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
4. TNFRSF11A-Associated Dysosteosclerosis: A Report of the Second Case and Characterization of the Phenotypic Spectrum.
- Author
-
Xue JY, Wang Z, Shinagawa S, Ohashi H, Otomo N, Elcioglu NH, Nakashima T, Nishimura G, Ikegawa S, and Guo L
- Subjects
- Asian People, Humans, Japan, Male, Middle Aged, Codon, Terminator, Exons, Osteosclerosis genetics, Point Mutation, Receptor Activator of Nuclear Factor-kappa B genetics
- Abstract
Dysosteosclerosis (DOS) is a distinct form of sclerosing bone disease characterized by irregular osteosclerosis and platyspondyly. DOS is genetically heterogeneous; however, only five cases with SLC29A3 mutations and a single case with a splice-site mutation of TNFRSF11A have been reported, and TNFRSF11A is also a causal gene for osteopetrosis, autosomal recessive 7 (OP-AR7). Thus, the causal genes of DOS and their genotype-phenotype associations remain unclear. In this study, we examined a Japanese patient with DOS and found a novel variant in TNFRSF11A. The homozygous variant was a G to T transversion at the first nucleotide of exon 9 (c.784G>T). Although the variant was predicted to cause a stop codon mutation (p.E262*), in silico evaluation of the exonic splicing elements followed by RT-PCR for the patient-derived cells showed that it caused aberrant splicing due to the change in the exonic splicing element and produced two types of aberrant transcripts: One caused a premature stop codon (p.E262Vfs*17) leading to nonsense mutation-mediated mRNA decay; the other produced a protein with interstitial deletion (p.E262_Q279del). The effects of the mutation on five splicing isoforms of TNFRSF11A were different from those in OP-AR7, but comparable with those in the first DOS with the TNFRSF11A mutation. Thus, we identified the second case of DOS caused by the TNFRSF11A splice-site mutation and confirmed the novel disease entity. © 2019 American Society for Bone and Mineral Research., (© 2019 American Society for Bone and Mineral Research.)
- Published
- 2019
- Full Text
- View/download PDF
5. [113th Scientific Meeting of the Japanese Society of Internal Medicine: Presidential Lecture: Invited Lecture: Molecular Mechanisms and Therapeutic Strategies for Muscular Dystrophies].
- Author
-
Toda T
- Subjects
- Alternative Splicing, Exons, Genetic Therapy, Humans, Internal Medicine, Japan, Muscular Dystrophies therapy, Regeneration, Societies, Medical, Muscular Dystrophies genetics
- Published
- 2016
6. A comprehensive search for mutations in the PKD1 and PKD2 in Japanese subjects with autosomal dominant polycystic kidney disease.
- Author
-
Kurashige M, Hanaoka K, Imamura M, Udagawa T, Kawaguchi Y, Hasegawa T, Hosoya T, Yokoo T, and Maeda S
- Subjects
- Adult, Aged, Alternative Splicing, Female, Genetic Association Studies, Genetic Loci, Genotype, Glomerular Filtration Rate, Humans, Japan, Male, Middle Aged, Phenotype, Polycystic Kidney, Autosomal Dominant diagnosis, Polymorphism, Single Nucleotide, Recombination, Genetic, Sequence Analysis, DNA, Asian People genetics, Mutation, Polycystic Kidney, Autosomal Dominant genetics, TRPP Cation Channels genetics
- Abstract
To elucidate the genotypic and phenotypic characteristics of autosomal dominant polycystic kidney disease (ADPKD) in Japanese populations, we performed a comprehensive search for mutations in PKD1 and PKD2 in 180 Japanese ADPKD patients from 161 unrelated families. We identified 112 (89 PKD1 and 23 PKD2) mutations within 135 families. Patients with PKD2 mutations account for 23.6% of all Japanese ADPKD families in this study. Seventy-five out of the 112 mutations have not been reported previously. The estimated glomerular filtration rate (eGFR) decline was significantly faster in patients with PKD1 mutations than in those with PKD2 mutations (-3.25 and -2.08 ml min(-1) year(-1) for PKD1 and PKD2, respectively, p < 0.01). These results indicate that mutations within PKD1 and PKD2 can be linked to most of the cases of Japanese ADPKD, and the renal function decline was faster in patients with PKD1 mutations than in those with PKD2 mutations also in the Japanese ADPKD. We also found that PKD2 mutations were more frequent in Japanese ADPKD than that in European or American ADPKD., (© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2015
- Full Text
- View/download PDF
7. Detection of alternative splice and gene duplication by RNA sequencing in Japanese flounder, Paralichthys olivaceus.
- Author
-
Wang W, Wang J, You F, Ma L, Yang X, Gao J, He Y, Qi J, Yu H, Wang Z, Wang X, Wu Z, and Zhang Q
- Subjects
- Alternative Splicing, Animals, DNA Transposable Elements, Gene Duplication, Genome, Haploidy, Japan, Polymorphism, Single Nucleotide, Sequence Analysis, RNA, Software, Transcriptome, Flounder genetics
- Abstract
Japanese flounder (Paralichthys olivaceus) is one of the economic important fish in China. Sexual dimorphism, especially the different growth rates and body sizes between two sexes, makes this fish a good model to investigate mechanisms responsible for such dimorphism for both fundamental questions in evolution and applied topics in aquaculture. However, the lack of "omics" data has hindered the process. The recent advent of RNA-sequencing technology provides a robust tool to further study characteristics of genomes of nonmodel species. Here, we performed de novo transcriptome sequencing for a double haploid Japanese flounder individual using Illumina sequencing. A single lane of paired-end sequencing produced more than 27 million reads. These reads were assembled into 107,318 nonredundant transcripts, half of which (51,563; 48.1%) were annotated by blastx to public protein database. A total of 1051 genes that had potential alternative splicings were detected by Chrysalis implemented in Trinity software. Four of 10 randomly picked genes were verified truly containing alternative splicing by cloning and Sanger sequencing. Notably, using a doubled haploid Japanese flounder individual allow us to analyze gene duplicates. In total, 3940 "single-nucleotide polymorphisms" were detected form 1859 genes, which may have happened gene duplicates. This study lays the foundation for structural and functional genomics studies in Japanese flounder., (Copyright © 2014 Wang et al.)
- Published
- 2014
- Full Text
- View/download PDF
8. Molecular analysis of the BCR-ABL1 kinase domain in chronic-phase chronic myelogenous leukemia treated with tyrosine kinase inhibitors in practice: study by the Nagasaki CML Study Group.
- Author
-
Itonaga H, Tsushima H, Imanishi D, Hata T, Doi Y, Mori S, Sasaki D, Hasegawa H, Matsuo E, Nakashima J, Kato T, Horai M, Taguchi M, Matsuo M, Taniguchi H, Makiyama J, Sato S, Horio K, Ando K, Moriwaki Y, Sawayama Y, Ogawa D, Yamasaki R, Takasaki Y, Imaizumi Y, Taguchi J, Kawaguchi Y, Yoshida S, Joh T, Moriuchi Y, Nonaka H, Soda H, Fukushima T, Nagai K, Kamihira S, Tomonaga M, Yanagihara K, and Miyazaki Y
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Analysis of Variance, Benzamides adverse effects, Benzamides therapeutic use, DNA Mutational Analysis, Dose-Response Relationship, Drug, Drug Resistance, Neoplasm genetics, Female, Gene Expression Regulation, Leukemic, Humans, Imatinib Mesylate, Japan, Leukemia, Myeloid, Chronic-Phase diagnosis, Male, Middle Aged, Piperazines adverse effects, Piperazines therapeutic use, Prospective Studies, Protein Kinase Inhibitors adverse effects, Pyrimidines adverse effects, Pyrimidines therapeutic use, Reverse Transcriptase Polymerase Chain Reaction, Risk Factors, Treatment Outcome, Young Adult, Fusion Proteins, bcr-abl genetics, Leukemia, Myeloid, Chronic-Phase drug therapy, Leukemia, Myeloid, Chronic-Phase genetics, Mutation, Protein Kinase Inhibitors therapeutic use
- Abstract
An appropriate trigger for BCR-ABL1 mutation analysis has not yet been established in unselected cohorts of chronic-phase chronic myelogenous leukemia patients. We examined 92 patients after 12 months of tyrosine kinase inhibitor (TKI) treatment in Nagasaki Prefecture, Japan. Univariate analysis revealed that significant factors associated with not attaining a major molecular response (MMR) were the presence of the minor BCR-ABL1 fusion gene, a low daily dose of TKI, and the emergence of BCR-ABL1 kinase domain mutations conferring resistance to imatinib. Factors associated with the loss of sustained MMR were a low daily dose of TKI and the emergence of alternatively spliced BCR-ABL1 mRNA with a 35-nucleotide insertion. Taken together, our results suggest that the search for BCR-ABL1 mutations should be initiated if patients have not achieved MMR following 12 months of TKI treatment., (Copyright © 2013 Elsevier Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
9. Molecular analysis of the genes causing recessive demyelinating Charcot-Marie-Tooth disease in Japan.
- Author
-
Hayashi M, Abe A, Murakami T, Yamao S, Arai H, Hattori H, Iai M, Watanabe K, Oka N, Chida K, Kishikawa Y, and Hayasaka K
- Subjects
- Adolescent, Adult, Aged, Alternative Splicing, Child, Child, Preschool, Female, Gene Frequency, Genotype, Humans, Japan, Male, Middle Aged, Mutation, Nerve Tissue Proteins genetics, Phenotype, Young Adult, Charcot-Marie-Tooth Disease genetics, Demyelinating Diseases genetics, Genes, Recessive
- Abstract
Charcot-Marie-Tooth disease (CMT), the most common hereditary neuropathy, has been classified into two types, demyelinating and axonal types. We previously analyzed the genes causing dominant demyelinating CMT in 227 Japanese patients to identify the genetic background, but could not find any mutations in 110 patients. To investigate the frequency of patients with autosomal recessive demyelinating CMT (CMT4) mutations, we analyzed the coding sequence of known causative genes of CMT4 in 103 demyelinating CMT patients, excluding seven patients owing to lack of specimens. We found one patient with a GDAP1 mutation, one patient with an MTMR2 mutation, two patients with SH3TC2/KIAA1985 mutations and three patients with FGD4 mutations. Twelve patients, including five previously detected patients with PRX mutations, were diagnosed as CMT4, accounting for 5.5% of demyelinating CMT. In the patient with GDAP1 mutation, only one mutation inherited from his mother was detected by genomic sequencing. Analysis by reverse transcription polymerase chain reaction using messenger RNA (mRNA) from the patient's leukocytes revealed the absence of transcription from the allele inherited from his father, suggesting the existence of one more mutation leading to a lack or destabilization of mRNA. Most patients carrying CMT4 gene mutations present with early-onset and slowly progressive symptoms, which may be associated with the function of mutants. We could not identify the disease-causing gene in 96 patients (about 45%). Further studies including studies with next-generation sequencers will be required to identify the causative gene in Japanese CMT.
- Published
- 2013
- Full Text
- View/download PDF
10. Unique haplotype in exon 3 of cone opsin mRNA affects splicing of its precursor, leading to congenital color vision defect.
- Author
-
Ueyama H, Muraki-Oda S, Yamade S, Tanabe S, Yamashita T, Shichida Y, and Ogita H
- Subjects
- Amino Acid Sequence, Asian People genetics, HEK293 Cells, Haplotypes, Humans, Japan, Male, Molecular Sequence Data, RNA, Messenger genetics, Alternative Splicing, Color Vision Defects genetics, Cone Opsins genetics, Exons genetics, Mutation, Missense, Rod Opsins genetics
- Abstract
We have analyzed L/M visual pigment gene arrays in 119 Japanese men with protanopia color vision defect and found that five had a normal gene order of L-M. Among the five men, two (identified as A376 and A642) had apparently normal L genes. To clarify their L gene defect, the whole L or M gene from A376 and control subjects was cloned in an expression vector. Total RNA extracted from the transfected HEK293 cells was analyzed by Northern blot and reverse transcription-polymerase chain reaction. The product from the cloned L gene of A376 was smaller than the normal control due to the absence of exon 3. To investigate such exon-skipping at splicing, minigenes of exon 3 accompanying introns 2 and 3 were prepared from A376, A642, and control subjects. The minigenes of A376 (L) and A642 (L) showed the product lacking exon 3 only, while the minigene of normal control N44 (L) showed the product retaining exon 3 only. Exchanging of introns 2 and 3 between the A376 (L) and N44 (L) minigenes showed that the skipping of exon 3 was caused by the exon itself. Seven differences in exon 3 between A376 (L) and N44 (L) were all within already-known polymorphisms as follows: G(151-3), C(153-1), G(155-3), A(171-1), T(171-3), G(178-1) and G(180-1) in A376 (L) and A642 (L), and A(151-3), A(153-1), C(155-3), G(171-1), G(171-3), A(178-1) and T(180-1) in N44 (L). An in vitro mutagenesis experiment with these nucleotides in the minigenes showed that exon 3 was completely skipped at splicing only in the haplotype observed in A376 (L) and A642 (L). These results suggest that complete skipping of exon 3 at splicing, due to the unique haplotype of the exon, causes loss of expression of L-opsin in these men., (Copyright © 2012 Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
11. Novel mutations of cholesteryl ester transfer protein (CETP) gene in Japanese hyperalphalipoproteinemic subjects.
- Author
-
Ohtani R, Inazu A, Noji Y, Wakasugi T, Miwa K, Tada H, Kawashiri MA, Noguchi T, Nohara A, Kobayashi J, Koizumi J, Yamagishi M, and Mabuchi H
- Subjects
- Aged, Alternative Splicing, Animals, COS Cells, Cells, Cultured, Chlorocebus aethiops, Cholesterol Ester Transfer Proteins blood, Female, Humans, Hyperlipoproteinemias blood, Hyperlipoproteinemias epidemiology, Japan epidemiology, Middle Aged, Mutation, Pedigree, Polymorphism, Restriction Fragment Length genetics, Sequence Analysis, DNA, Cholesterol Ester Transfer Proteins genetics, Hyperlipoproteinemias genetics
- Abstract
Background: The half of hyperalphalipoproteinemia (HALP) in Japan is caused by CETP gene mutations. Other than two prevalent mutations (D442G and Intron 14 splicing donor site +1G>A), some rare CETP mutations are found in Japanese HALP subjects., Methods: CETP gene analysis of genomic DNA from subjects was performed by restriction fragment length polymorphism (RFLP) and sequencing analysis. Mutations which were suspected to cause a splicing defect or a protein secretion defect were investigated in COS-1 cells transfected with a CETP minigene construct or a cDNA expression vector., Results: Each of three subjects was identified as a carrier of CETP gene mutation of a compound heterozygote of c.653_654delGGinsAAAC and Intron 14 splicing donor site +1G>A, a heterozygote of c.658G>A or a homozygote of L261R. The c.658G>A mutation was located at the last nucleotide of exon 7, and it was confirmed to cause splicing abnormality revealed by the CETP minigene analysis. The L261R CETP was not secreted to conditioned media of the cells., Conclusions: Three novel CETP gene mutations are responsible for HALP by CETP deficiency. It is predicted that there are more rare CETP gene mutations in Japanese, and these multiple rare mutations alone or a combination with each of prevalent mutations is responsible for mild-to-moderate or marked HALP, respectively., (Copyright © 2011 Elsevier B.V. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
12. Alternative use of multiple exons 1 of aromatase gene in cancerous and normal breast tissues from women over the age of 80 years.
- Author
-
Honma N, Takubo K, Sawabe M, Arai T, Akiyama F, Sakamoto G, Utsumi T, Yoshimura N, and Harada N
- Subjects
- Adult, Aged, Breast Neoplasms epidemiology, Breast Neoplasms genetics, Carcinoma enzymology, Carcinoma epidemiology, Carcinoma genetics, Carcinoma, Ductal, Breast epidemiology, Carcinoma, Ductal, Breast genetics, Estrogens, Female, Gene Expression Regulation, Neoplastic, Humans, Isoenzymes genetics, Japan epidemiology, Middle Aged, Neoplasms, Hormone-Dependent enzymology, Neoplasms, Hormone-Dependent epidemiology, Neoplasms, Hormone-Dependent genetics, RNA, Messenger genetics, RNA, Neoplasm genetics, Receptors, Estrogen analysis, Aged, 80 and over physiology, Alternative Splicing, Aromatase genetics, Breast enzymology, Breast Neoplasms enzymology, Carcinoma, Ductal, Breast enzymology, Exons genetics, Neoplasm Proteins genetics
- Abstract
Introduction: Peripherally localized aromatase, which converts circulating androgens into estrogens, is important in the pathogenesis of postmenopausal breast carcinomas. We have previously shown that aromatase mRNA levels are higher in elderly breast carcinomas (EldCa) than breast carcinomas of the control group (ContCa) or normal breast tissues. Aromatase expression has been reported to be regulated through the alternative use of multiple exons 1 (exons 1a-1f and so on); however, the preferential usage of exons 1 in elderly breast tissue has never been systematically examined. In order to properly treat and protect against EldCa, the regulation mechanism of aromatase expression in elderly breast tissues should be elucidated. The aim of the present study is to elucidate whether there are any specific patterns in use of multiple exons 1 in elderly breast tissue., Methods: Usage of multiple exons 1 of the aromatase gene and mRNA levels of aromatase were examined by reverse transcription-polymerase chain reaction analysis in breast tissues of 38 elderly patients with breast cancer (age 80-99), and the results were compared with those in 35 patients of the control group (age 37-70). One-factor analysis of variance and the Scheffé test were used for the comparison of aromatase mRNA levels. Patterns of preferential utilization of multiple exons 1 of the aromatase gene were compared by chi2 test for independence or Fisher exact test for independence using a contingency table., Results: Exon 1d was utilized much more frequently in elderly tissue than in the control group irrespective of cancerous or normal tissue (EldCa, 36/38, 95% versus ContCa, 7/35, 20%, P < 0.0001; normal tissue of the elderly, EldNorm, 30/34, 88% versus normal tissue of controls, ContNorm, 2/29, 7%, P < 0.0001). Twenty EldCa (53%) and 12 EldNorm (35%) used both exons 1c and 1d; however, their dominance was reversed (EldCa, all 1d > 1c; EldNorm, all 1c > 1d)., Conclusions: Elderly breast tissues exhibited specific patterns in use of multiple exons 1, which at least partly explained the higher aromatase levels in EldCa. The mechanisms of how these specific patterns occur during aging and carcinogenesis should be further examined.
- Published
- 2009
- Full Text
- View/download PDF
13. C117T variant in the SMN1 gene found in the Japanese population.
- Author
-
Sadewa AH, Harada Y, Sasongko TH, Matsuo M, and Nishio H
- Subjects
- Alternative Splicing, Humans, Japan, Muscular Atrophy, Spinal genetics, Reverse Transcriptase Polymerase Chain Reaction, SMN Complex Proteins, Survival of Motor Neuron 1 Protein, Survival of Motor Neuron 2 Protein, Asian People genetics, Cyclic AMP Response Element-Binding Protein genetics, Genetic Variation, Nerve Tissue Proteins genetics, RNA-Binding Proteins genetics
- Abstract
Background: The SMN genes are closely related to the development of spinal muscular atrophy (SMA); mutated SMN1 causes SMA and functional SMN2 modifies the severity of SMA. SMN1 and SMN2 are almost identical, being distinguished by only five base pair substitutions located at the 3'-end of the genes. Recently, a synonymous DNA variant, C117T, has been identified at the first codon of SMN2 exon 2a in the Caucasian population. It is still a question whether the variant is specific to the Caucasian population, and whether it is found only in SMN2. In order to address these questions, Japanese populations were screened for the presence of C117T in the SMN genes., Methods: To detect the C117T variant in a Japanese population, polymerase chain reaction-restriction fragment length polymorphism was performed in 33 SMA patients homozygous for SMN1 deletion and 106 control individuals. Reverse transcription-polymerase chain reaction (RT-PCR) was performed to clarify whether the variant affects the splicing process of the SMN1 gene., Results: The C117T variant was found in one out of 33 Japanese SMA patients (3.0%) and in seven out of 106 Japanese control individuals (6.6%). There was no significant difference between frequencies in the present data and those reported from the Caucasian population. Notably, the C117T variant was also detected in the SMN1 gene; a control individual with homozygous SMN2 deletion was found to have the variant on one of the SMN1 genes. RT-PCR indicated that this variant of the SMN1 gene was normally transcribed and did not affect the splicing process in this individual., Conclusions: The C117T variant was found not only in the Caucasian population, but also in the Japanese population. In addition, the variant was not specific to SMN2: it was also found in SMN1. RT-PCR indicated that the variant did not affect the splicing process.
- Published
- 2007
- Full Text
- View/download PDF
14. Examination of PPP1R3B as a candidate gene for the type 2 diabetes and MODY loci on chromosome 8p23.
- Author
-
Dunn JS, Mlynarski WM, Pezzolesi MG, Borowiec M, Powers C, Krolewski AS, and Doria A
- Subjects
- 5' Untranslated Regions genetics, Alternative Splicing, Female, Gene Frequency, Humans, Introns genetics, Japan, Male, Middle Aged, Mutation genetics, Reverse Transcriptase Polymerase Chain Reaction, White People genetics, Chromosomes, Human, Pair 8 genetics, Diabetes Mellitus, Type 2 genetics, Phosphoprotein Phosphatases genetics
- Abstract
The product of the PPP1R3B gene (G(L)) is the regulatory subunit of PP1 - a serine/threonine phosphatase involved in the modulation of glycogen synthesis in the liver and skeletal muscle. The PPP1R3B gene is located on chromosome 8p23 in a region that has been linked with type 2 diabetes and maturity-onset diabetes of the young (MODY). We examined whether sequence variants at the PPP1R3B locus are responsible for the linkage with diabetes observed at this location. RT-PCR analysis revealed the existence of two alternative promoters. These and the two exons of this gene were sequenced in the probands of 13 Joslin families showing the strongest evidence of linkage at 8p23. A total of 20 variants were observed: two in the 5' flanking region, one in the intron (9 bp 5' of exon 2), and 17 in the 3' UTR. The intronic variant generated a new acceptor splice site, resulting in an alternative splice variant with a longer 5' UTR. However, neither this nor other variants segregated with diabetes in the 13 'linked' families. Furthermore, allele frequencies were similar in 90 family probands from the Joslin Study and 347 unrelated controls. Thus, genetic variability in the PPP1R3B gene does not appear to contribute to diabetes in our mostly Caucasian families. However, a role cannot be excluded in other populations such as the Japanese, among whom linkage to diabetes is also observed at 8p23 and a non-synonymous mutation has been detected in the PPP1R3B gene.
- Published
- 2006
- Full Text
- View/download PDF
15. Coding SNP in tenascin-C Fn-III-D domain associates with adult asthma.
- Author
-
Matsuda A, Hirota T, Akahoshi M, Shimizu M, Tamari M, Miyatake A, Takahashi A, Nakashima K, Takahashi N, Obara K, Yuyama N, Doi S, Kamogawa Y, Enomoto T, Ohshima K, Tsunoda T, Miyatake S, Fujita K, Kusakabe M, Izuhara K, Nakamura Y, Hopkin J, and Shirakawa T
- Subjects
- Adult, Alternative Splicing, Amino Acid Substitution, Case-Control Studies, Computer Simulation, Fibronectins metabolism, Haplotypes, Humans, Isoleucine genetics, Japan, Leucine genetics, Lung immunology, Protein Structure, Tertiary, Tenascin analysis, Asthma genetics, Polymorphism, Single Nucleotide, Tenascin genetics, Tenascin metabolism
- Abstract
The extracellular matrix glycoprotein tenascin-C (TNC) has been accepted as a valuable histopathological subepithelial marker for evaluating the severity of asthmatic disease and the therapeutic response to drugs. We found an association between an adult asthma and an SNP encoding TNC fibronectin type III-D (Fn-III-D) domain in a case-control study between a Japanese population including 446 adult asthmatic patients and 658 normal healthy controls. The SNP (44513A/T in exon 17) strongly associates with adult bronchial asthma (chi2 test, P=0.00019, Odds ratio=1.76, 95% confidence interval=1.31-2.36). This coding SNP induces an amino acid substitution (Leu1677Ile) within the Fn-III-D domain of the alternative splicing region. Computer-assisted protein structure modeling suggests that the substituted amino acid locates at the outer edge of the beta-sheet in Fn-III-D domain and causes instability of this beta-sheet. As the TNC fibronectin-III domain has molecular elasticity, the structural change may affect the integrity and stiffness of asthmatic airways. In addition, TNC expression in lung fibroblasts increases with Th2 immune cytokine stimulation. Thus, Leu1677Ile may be valuable marker for evaluating the risk for developing asthma and plays a role in its pathogenesis.
- Published
- 2005
- Full Text
- View/download PDF
16. Severe combined immunodeficiency caused by a splicing abnormality of the CD3delta gene.
- Author
-
Takada H, Nomura A, Roifman CM, and Hara T
- Subjects
- Asian People genetics, Female, Humans, Infant, Japan, Lymphocytes metabolism, Male, Mutation, Thymus Gland abnormalities, Alternative Splicing, CD3 Complex genetics, Introns, Severe Combined Immunodeficiency genetics
- Abstract
Unlabelled: CD3delta deficiency is a recently identified rare form of severe combined immunodeficiency. We analysed the CD3delta gene in a Japanese family with severe combined immunodeficiency. The patients lacked T-cells with normal numbers of B-cells and natural killer cells in peripheral blood. We found a novel homozygous mutation in the splicing acceptor site of intron 2 (IVS2-2A --> G) in these patients. Analysis of patients' mononuclear cells revealed the CD3delta splicing abnormality. Chest X-ray films and computed tomography revealed small sized thymuses in these patients., Conclusion: The CD3delta gene should be analysed in patients with severe combined immunodeficiency lacking T-cells with normal B- and natural killer cells irrespective of the thymus size.
- Published
- 2005
- Full Text
- View/download PDF
17. A novel cryptic exon identified in the 3' region of intron 2 of the human dystrophin gene.
- Author
-
Tran VK, Zhang Z, Yagi M, Nishiyama A, Habara Y, Takeshima Y, and Matsuo M
- Subjects
- Alternative Splicing, Base Sequence, Child, Preschool, Consensus Sequence, Conserved Sequence, DNA blood, Humans, Japan, Lymphocytes metabolism, Male, Molecular Sequence Data, Nucleic Acid Amplification Techniques, Polymerase Chain Reaction, Promoter Regions, Genetic, RNA Splice Sites, RNA, Messenger analysis, RNA, Messenger genetics, Reverse Transcriptase Polymerase Chain Reaction, Sequence Analysis, DNA, Transcription, Genetic, 3' Untranslated Regions, Dystrophin genetics, Exons, Introns
- Abstract
The dystrophin gene, which is mutated in Duchenne muscular dystrophy (DMD), is the largest known human gene and is characterized by the huge size of its introns. Intron 2, the second largest intron, is 170-kb long and has been shown to include a 140-bp cryptic exon (exon 2a) in its 5' region. The rest of this intron has no known function. In this study, we find that another cryptic exon, located in the 3' region of intron 2, is activated in a promoter- or tissue-specific manner. An unknown 98-bp insertion precisely between exons 2 and 3 was identified in one of the dystrophin mRNAs from lymphocytes of a DMD patient with a duplication of exon 2. This 98-bp sequence, located in the 3' region of intron 2, was found to possess a branch point, acceptor and donor splice-site consensus sequences, and an exonic splicing enhancer sequence, and thus is a novel exon, which we named "exon 2b." In lymphocytes, exon 2b incorporation was detected in the muscle-specific, promoter-driven transcript. Five of 20 normal human tissue mRNAs, including cardiac and skeletal muscle mRNAs, were confirmed to contain a fragment extending from exon 1 to exon 2b by reverse transcription PCR amplification, indicating that exon 2b is activated in a tissue-specific manner. This provides a clue to a novel cause of dystrophinopathy.
- Published
- 2005
- Full Text
- View/download PDF
18. Mutational and structural analysis of Japanese patients with mucopolysaccharidosis type II.
- Author
-
Kato T, Kato Z, Kuratsubo I, Tanaka N, Ishigami T, Kajihara JI, Sukegawa-Hayasaka K, Orii K, Isogai K, Fukao T, Shimozawa N, Orii T, Kondo N, and Suzuki Y
- Subjects
- Adolescent, Adult, Alternative Splicing, Amino Acid Sequence, Base Sequence, Binding Sites, Child, Child, Preschool, Codon, Nonsense, Frameshift Mutation, Humans, Iduronate Sulfatase chemistry, Japan, Models, Molecular, Mutation, Missense, Protein Structure, Tertiary, Sequence Deletion, DNA Mutational Analysis, Iduronate Sulfatase genetics, Mucopolysaccharidosis II genetics, Mutation
- Abstract
We investigated mutations of the iduronate-2-sulfatase (I2S) gene and structural characteristics of I2S to clarify genotype/phenotype relationships in 18 Japanese patients with mucopolysaccharidosis type II. The I2S gene was analyzed in five patients with a severe phenotype and in 13 patients with an attenuated phenotype. The tertiary structural model of the human I2S was constructed by homology modeling using the arylsulfatase structure as a template. We identified four missense mutations and a nonsense mutation in the severe phenotype; four missense, two nonsense, three frame shifts, and one each of splice and amino acid deletion in the attenuated phenotype. Seven of them (L73del, Q75X, G140R, C171R, V401 fs, C422 fs, and H441 fs) were novel mutations. Structural analysis indicated that the residues of the mutations found in the severe phenotype would have direct interactions with the active site residues or should break the hydrophobic core domain of I2S, whereas residues of the missense mutations found in the attenuated phenotype were located in the peripheral region. In addition, effects by deletion or frameshift mutations could also be interpreted by the structure. Structural analysis of mutant proteins would help in understanding the genotype/phenotype relationships of Hunter disease.
- Published
- 2005
- Full Text
- View/download PDF
19. Inactivating mutations of the human base excision repair gene NEIL1 in gastric cancer.
- Author
-
Shinmura K, Tao H, Goto M, Igarashi H, Taniguchi T, Maekawa M, Takezaki T, and Sugimura H
- Subjects
- Alternative Splicing, Cell Nucleus metabolism, DNA Glycosylases metabolism, Humans, Japan epidemiology, Polymorphism, Genetic, RNA, Messenger genetics, RNA, Messenger metabolism, Recombinant Proteins genetics, Recombinant Proteins metabolism, Stomach Neoplasms blood, Stomach Neoplasms epidemiology, Subcellular Fractions, Tumor Cells, Cultured, DNA Glycosylases genetics, DNA Repair, Mutation genetics, Stomach Neoplasms genetics
- Abstract
Oxidized DNA base lesions, such as thymine glycol (Tg) and 8-hydroxyguanine, are often toxic and mutagenic and have been implicated in carcinogenesis. To clarify whether NEIL1 protein, which exhibits excision repair activity towards such base lesions, is involved in gastric carcinogenesis, we examined 71 primary gastric cancers from Japanese patients and four gastric cancer cell lines for mutations and genetic polymorphisms of the NEIL1 gene. We also examined 20 blood samples from Chinese patients for NEIL1 genetic polymorphisms. Three mutations (c.82_84delGAG:p.Glu28del, c.936G > A and c.1000A > G:p.Arg334Gly) and two genetic polymorphisms were identified. When the excision repair activity towards double-stranded oligonucleotide containing a Tg:A base pair was compared among six types of recombinant NEIL1 proteins, p.Glu28del-type NEIL1, found in a primary case, was found to exhibit an extremely low activity level. Moreover, c.936G > A, located in the last nucleotide of exon 10 and detected in the KATO-III cell line, was shown to be associated with a splicing abnormality using an in vivo splicing assay. An immunofluorescence analysis showed that the wild-type NEIL1 protein, but not the truncated protein encoded by the abnormal transcript arising from the c.936G > A mutation, was localized in the nucleus, suggesting that the truncated protein is unlikely to be capable of repairing nuclear DNA. An expression analysis revealed that NEIL1 mRNA expression was reduced in six of 13 (46%) primary gastric cancer specimens that were examined. These results suggest that low NEIL1 activities arising from mutations and reduced expression may be involved in the pathogenesis in a subset of gastric cancers.
- Published
- 2004
- Full Text
- View/download PDF
20. A novel splice-site variant of the base excision repair gene MYH is associated with production of an aberrant mRNA transcript encoding a truncated MYH protein not localized in the nucleus.
- Author
-
Tao H, Shinmura K, Hanaoka T, Natsukawa S, Shaura K, Koizumi Y, Kasuga Y, Ozawa T, Tsujinaka T, Li Z, Yamaguchi S, Yokota J, Sugimura H, and Tsugane S
- Subjects
- Adult, Aged, Aged, 80 and over, Case-Control Studies, DNA Glycosylases metabolism, Female, Genotype, Heterozygote, Humans, Japan epidemiology, Male, Middle Aged, Mutation genetics, Polymerase Chain Reaction, Polymorphism, Single-Stranded Conformational, RNA, Messenger metabolism, Stomach Neoplasms epidemiology, Stomach Neoplasms pathology, Alternative Splicing, Cell Nucleus metabolism, DNA Glycosylases genetics, DNA Repair, Guanine analogs & derivatives, RNA, Messenger genetics, Stomach Neoplasms genetics
- Abstract
The MYH gene encodes a DNA glycosylase involved in the excision repair of adenines paired with 8-hydroxyguanines, a major component of oxidative DNA damage, and bi-allelic germline MYH mutations have been reported to predispose individuals to multiple colorectal adenomas and carcinoma. To determine whether the MYH gene is involved in gastric carcinogenesis, we examined blood specimens from 20 Japanese familial gastric cancer (GC) patients for MYH mutations by polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) analysis followed by direct sequencing. Bi-allelic germline MYH mutations were not found in any of the specimens, but in addition to four known variants, a novel splice-site variant, IVS10-2A > G (c.892-2A > G), was found in two patients as its heterozygote. Reverse transcription-PCR analysis revealed that the IVS10-2A > G variant caused the production of an aberrant mRNA transcript encoding a truncated MYH protein. Immunofluorescence analysis showed that the wild-type MYH protein, but not the variant-type, is localized in the nucleus. We then searched for the IVS10-2A > G variant in 128 digestive tract cancer patients by PCR with confronting two-pair primers, and eight cancers from six patients with the IVS10-2A/G genotype were identified. However, no other germline MYH mutations or inactivation of the remaining wild-type allele was detected. We next tested the presumed correlation of the IVS10-2G allele with GC risk in a case-control study of 148 GC cases and 292 controls, but no significant difference in the distribution of the IVS10-2A > G variant was found between the cases and controls. Interestingly, the homozygote for the IVS10-2G allele was found in one GC case, but not in any controls. These results suggested that the ability to repair 8-hydroxyguanine in nuclear DNA may differ among Japanese individuals due to the splicing abnormality based on the MYH IVS10-2A > G variant, and that the bi-allelic IVS10-2A > G variation may be responsible for the occurrence of GC.
- Published
- 2004
- Full Text
- View/download PDF
21. Molecular basis of Japanese variants of pyrimidine 5'-nucleotidase deficiency.
- Author
-
Kanno H, Takizawa T, Miwa S, and Fujii H
- Subjects
- Adolescent, Adult, Alternative Splicing, Animals, Base Sequence, COS Cells, Child, Child, Preschool, DNA Mutational Analysis, Female, Humans, Japan, Male, Middle Aged, Molecular Sequence Data, Pyrimidine Nucleotides metabolism, 5'-Nucleotidase deficiency, 5'-Nucleotidase genetics, Anemia, Hemolytic enzymology, Erythrocytes enzymology, Mutation
- Abstract
The type-I isoform of pyrimidine 5'-nucleotidase (P5N-I) has an important role in the catabolism of pyrimidine mononucleotides during erythroid maturation. Two alternatively spliced forms of P5N-I mRNA have been identified, and we found another alternatively spliced form in reticulocytes, which included an additional 87-bp sequence. The sequence is located 6.2-kb downstream of the exon 2 and 2.7-kb upstream of the exon 3 sequence; consequently, the P5N-I gene encodes 11 exons, which span approximately 48 kb. We identified five novel mutations in nine families with P5N-I deficiency: two missense mutations (425C, 721C), one splice mutation (339C), one 1-bp insertion (251-insA-252) and one 9-bp deletion (del 192-200). All patients were homozygous for each mutation. The mutant P5N-I with 721C (G241R) had lower affinity for cytidine monophosphate, suggesting that Gly241 is important for substrate binding. Haplotype analysis showed that 721C, which had been identified in five unrelated families, was a founder mutation. The mutant P5N was then expressed in Cos-7. The degradation of P5N with 425C (L142P) was significantly faster than a wild-type control, and proteasome inhibitors restored the stability of L142P. These data suggest that L142P increases susceptibility to the degradation by the ubiquitin-proteasome pathway.
- Published
- 2004
- Full Text
- View/download PDF
22. Single-strand conformation polymorphism analysis of the FMR1 gene in autistic and mentally retarded children in Japan.
- Author
-
Shinahara K, Saijo T, Mori K, and Kuroda Y
- Subjects
- Alternative Splicing, Base Sequence, Case-Control Studies, Child, DNA Mutational Analysis, Exons, Female, Fragile X Mental Retardation Protein, Humans, Japan, Male, Molecular Sequence Data, Point Mutation, Polymorphism, Single-Stranded Conformational, Autistic Disorder genetics, Intellectual Disability genetics, Nerve Tissue Proteins genetics, RNA-Binding Proteins
- Abstract
Fragile X syndrome is one of the most common causes of mental retardation in males, and patients with fragile X syndrome occasionally develop autism. It is usually caused by an expansion of the trinucleotide repeat in the 5'-untranslated region of the FMR1 gene, but in a small number of patients deletions and point mutations have been identified. We screened all 17 exons of the FMR1 gene for mutations in 90 autistic or mentally retarded children using polymerase chain reaction (PCR)-single strand conformation polymorphism (SSCP) analysis. No mutations were found in 76 male patients. However, one female patient was heterozygous for a normal allele and a mutant allele with an A to C substitution at nucleotide 879 in exon 9. This mutation was not found in 50 controls. Reverse transcription-PCR revealed that a large proportion of the mutant transcripts were spliced aberrantly, causing premature termination of the protein synthesis. Although uncommon, point mutations in the FMR1 gene may be a cause of autism and mental retardation in Japanese patients.
- Published
- 2004
- Full Text
- View/download PDF
23. Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects.
- Author
-
Wenyi Z, Suzuki S, Hirai M, Hinokio Y, Tanizawa Y, Matsutani A, Satoh J, and Oka Y
- Subjects
- Aged, Alternative Splicing, Asian People genetics, Blood Glucose metabolism, Diabetes Mellitus, Type 2 diet therapy, Diabetes Mellitus, Type 2 drug therapy, Female, Gene Amplification, Glucose Tolerance Test, Humans, Insulin blood, Insulin Resistance genetics, Japan, Male, Middle Aged, Polymerase Chain Reaction, Polymorphism, Restriction Fragment Length, Diabetes Mellitus, Type 2 genetics, Genetic Predisposition to Disease genetics, Glucose Intolerance genetics, Polymorphism, Single Nucleotide, Urotensins genetics
- Abstract
Aim/hypothesis: Urotensin II is a potent vasoactive hormone and the urotensin II gene (UTS2) is localized to 1p36-p32, one of the regions reported to show possible linkage with Type 2 diabetes in Japanese subjects. The aim of this study is to investigate a possible contribution of SNPs in the UTS2 gene to the development of Type 2 diabetes., Methods: We surveyed SNPs in the UTS2 gene in 152 Japanese subjects with Type 2 diabetes mellitus and two control Japanese cohorts: one consisting of 122 elderly subjects who met stringent criteria for being non-diabetic, including being older than 60 years of age with no evidence of diabetes (HbA(1c)<5.6%), and another 268 subjects with normal glucose tolerance., Results: We identified two SNPs with amino acid substitutions, designated T21M and S89N. The allele frequency of 89N was higher in Type 2 diabetic patients than in both elderly normal subjects (p=0.0018) and subjects with normal glucose tolerance (p=0.0011), whereas the allele frequency of T21M was essentially identical in these three groups. Furthermore, in the subjects with normal glucose tolerance, 89N was associated with higher insulin concentrations on oral glucose tolerance test, suggesting reduced insulin sensitivity in subjects with 89N., Conclusion/interpretation: These results strongly suggest that the S89N polymorphism in the UTS2 gene is associated with the development of Type 2 diabetes, via insulin sensitivity, in Japanese subjects.
- Published
- 2003
- Full Text
- View/download PDF
24. Novel alternatively spliced variant with a deletion of 52 BP in exon 6 of the progesterone receptor gene is observed frequently in breast cancer tissues.
- Author
-
Hisatomi H, Kohno N, Wakita K, Nagao K, Hirata H, Hikiji K, and Harada S
- Subjects
- Adult, Aged, Biomarkers, Tumor metabolism, Breast Neoplasms diagnosis, Case-Control Studies, Female, Gene Expression Regulation, Neoplastic, Humans, Japan, Middle Aged, Molecular Sequence Data, Prognosis, RNA, Messenger genetics, RNA, Neoplasm genetics, RNA, Neoplasm metabolism, Receptors, Progesterone metabolism, Alternative Splicing, Biomarkers, Tumor genetics, Breast metabolism, Breast Neoplasms genetics, Exons genetics, Gene Deletion, RNA, Messenger metabolism, Receptors, Progesterone genetics
- Abstract
The human progesterone receptor (PR) is a ligand-activated nuclear transcription factor that mediates progesterone action in target tissues. We found a novel alternatively spliced variant (ASV) of the PR mRNA in breast cancer tissues. The deleted transcript was characterized by an out-of-frame deletion of 52 bp in exon 6 (PR delta6/2 ASV). The PR delta6/2 ASV mRNA results in a partial defect in the region of the ligand-binding domain of the hormone receptor, where conserved residues are missing from the core of the protein. To clarify the clinical significance of the PR delta6/2 ASV, we investigated the expression of this ASV in noncancerous and cancerous tissues from patients with breast cancer using RT-PCR. The novel PR delta6/2 mRNA was detected in 24 of 39 (61.5%) cancerous tissues and in 3 of 39 (7.7%) noncancerous tissues from patients with breast cancer. PR delta6/2 ASV mRNA was expressed more frequently in breast cancer tissues than in noncancerous tissues (p < 0.0001), which suggests a possible relationship between the expression of PR delta6/2 and breast cancer. Our observations may provide a novel strategy for the genetic diagnosis of breast cancer., (Copyright 2003 Wiley-Liss, Inc.)
- Published
- 2003
- Full Text
- View/download PDF
25. Expression of a novel splicing variant deleting exons 4 and 6 of the progesterone receptor gene is a rare event in breast cancer.
- Author
-
Nagao K, Kohno N, Wakita K, Hikiji K, Yamamoto S, Hirata H, and Hisatomi H
- Subjects
- Adult, Aged, Breast Neoplasms diagnosis, Female, Gene Expression Regulation, Neoplastic, Humans, Japan, Middle Aged, Molecular Sequence Data, Prognosis, RNA, Messenger genetics, RNA, Neoplasm genetics, RNA, Neoplasm metabolism, Receptors, Progesterone metabolism, Tumor Cells, Cultured, Alternative Splicing, Breast Neoplasms genetics, Exons genetics, Gene Deletion, RNA, Messenger metabolism, Receptors, Progesterone genetics
- Abstract
We identified a novel alternatively spliced isoform of PR mRNA in breast cancer tissues. The deleted transcript was characterized by an out-of-frame deletion of 437 bp, corresponding to the complete loss of exons 4 and 6 (PR delta4+6 ASV). PR delta4+6 ASV will result in a partial defect in the region of the ligand-binding domain of hormone receptors, suggesting that the conserved residues are missing from the core of the protein. In the limited number of samples studied, a novel PR delta4+6 mRNA was detected in 1 of 45 (2.2%) non-cancerous tissues of patients with breast cancer, in 5 of 45 (11.1%) cancerous tissues of patients with breast cancer. Loss of both exons 4 and 6 will be induced by incomplete splicing and/or repair mechanism. Further studies are necessary to establish the biological significance of this alternative splicing. The expressions of ASVs that induced the mimic PR transcripts need to be considered when designing strategies for regulation analysis of the PR gene.
- Published
- 2003
26. So many choices, so little money.
- Author
-
Pennisi E
- Subjects
- Alternative Splicing, Animals, Computing Methodologies, DNA, Complementary, Databases, Factual, Europe, Genome, Genome, Human, Haplotypes, Human Genome Project, Humans, International Cooperation, Japan, National Institutes of Health (U.S.), Polymorphism, Single Nucleotide, United States, Computational Biology, Genomics, Proteome, Research Support as Topic, Sequence Analysis, DNA
- Published
- 2001
- Full Text
- View/download PDF
27. A novel splice acceptor site mutation of protein S gene in affected individuals with type I protein S deficiency: allelic exclusion of the mutant gene.
- Author
-
Nakahara M, Iida H, Urata M, Fujise M, Wakiyama M, Kinoshita S, Tsuda H, Okamura T, Yao K, Yao T, and Hamasaki N
- Subjects
- Alleles, Asian People, Base Sequence, Exons, Female, Humans, Introns, Japan, Male, Mesenteric Veins, Middle Aged, Nuclear Family, RNA, Messenger genetics, Reverse Transcriptase Polymerase Chain Reaction, Sex Characteristics, Transcription, Genetic, Venous Thrombosis blood, Alternative Splicing, Polymorphism, Restriction Fragment Length, Protein S genetics, Protein S Deficiency genetics, Venous Thrombosis genetics
- Abstract
Sequencing studies of the protein S gene (PROS1) in a Japanese patient suffering from recurrent thrombosis revealed the following. The proband and his first daughter, but not the second daughter, were having the type I protein S (PS) deficiency due to a novel point mutation from A to G at the intronic acceptor splice site in intron 13 of the PROS1. In the affected daughter, exclusion of the aberrant allele was assessed by the BstX1 dimorphism of PROS1 at Pro626 (CCG/CCA). The reduced PS activities in the proband and his first daughter were apparently due to defective production of mRNA from the mutant allele.
- Published
- 2001
- Full Text
- View/download PDF
28. Mutations of the PKD1 gene among Japanese autosomal dominant polycystic kidney disease patients, including one heterozygous mutation identified in members of the same family.
- Author
-
Mizoguchi M, Tamura T, Yamaki A, Higashihara E, and Shimizu Y
- Subjects
- Adult, Alternative Splicing, Amino Acid Substitution, Asian People, Base Sequence, Europe, Exons, Female, Genetic Markers, Humans, Introns, Japan, Male, Membrane Proteins genetics, Middle Aged, Mutation, Missense, Pedigree, Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction, Sequence Deletion, TRPP Cation Channels, White People, Mutation, Polycystic Kidney, Autosomal Dominant genetics, Proteins genetics
- Abstract
More than 80 mutations of the PKD1 gene have been reported, mostly in patients from Western Europe. New techniques are being used to detect an increasing number of mutations, even in the homologous region of the PKD1 gene. Polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) or denaturing high-performance liquid chromatography (DHPLC) analyses were performed in the present study to screen mutations from exon 23 to exon 46 in the PKD1 gene and in the entire PKD2 gene. When an abnormal pattern was found in PCR-SSCP or DHPLC, the PCR products were directly sequenced. Four mutations were identified in the PKD1 gene: a missense mutation (C47413T causing T3509M in exon 35), a splicing mutation (del 20bp in 75 bp of intron 43), and two nonsense mutations (C48566A causing C3693X in exon 38, and C51237T causing Q4124X in exon 45). The nonsense mutation Q4124X existed in only two of three affected sib members in family K68. The pattern of the restriction enzyme digest and the haplotype analysis confirmed the presence of a heterozygous mutation in the family. Fifteen single nucleotide polymorphisms were identified in this study. Two of them (C50439A and C51659T) can be used as intragenic polymorphic markers.
- Published
- 2001
- Full Text
- View/download PDF
29. Genetic alterations in the human Tcf-4 gene in Japanese patients with sporadic gastrointestinal cancers with microsatellite instability.
- Author
-
Saeki H, Tanaka S, Tokunaga E, Kawaguchi H, Ikeda Y, Maehara Y, and Sugimachi K
- Subjects
- Adenocarcinoma ethnology, Adenocarcinoma pathology, Alternative Splicing, Amino Acid Sequence, Base Sequence, Colorectal Neoplasms ethnology, Colorectal Neoplasms genetics, Colorectal Neoplasms pathology, DNA Mutational Analysis, DNA, Neoplasm genetics, Gastrointestinal Neoplasms ethnology, Gene Expression Regulation, Neoplastic, Humans, Japan epidemiology, Molecular Sequence Data, Reverse Transcriptase Polymerase Chain Reaction, Sequence Alignment, Sequence Analysis, DNA, Sequence Deletion, Sequence Homology, Amino Acid, Stomach Neoplasms ethnology, Stomach Neoplasms genetics, Stomach Neoplasms pathology, TCF Transcription Factors, Transcription Factor 7-Like 2 Protein, Transcriptional Activation, Tumor Cells, Cultured, Adenocarcinoma genetics, Gastrointestinal Neoplasms genetics, Microsatellite Repeats, Neoplasm Proteins genetics, Protein Isoforms genetics, Transcription Factors genetics
- Abstract
Disruption of the APC/beta-catenin/Tcf pathway has been proposed as an important step in the development of cancer. The Tcf-4 transcription factor gene was reported to be one of the targets of microsatellite instability (MSI) in colorectal cancers in with MSI. We carried out a sequencing analysis of the Tcf-4 gene in 41 Japanese patients with gastrointestinal tumors with MSI as well as in cancer cell lines. Three of 21 (14.3%) colorectal tumors with MSI contained a mutant Tcf-4 gene encoding 1-bp deletion in an (A)9 repeat, leading to carboxyl terminal truncation of Tcf-4 protein. No Tcf-4 mutations were detected in 20 gastric tumors with MSI, or in gastric cancer cell lines. Additionally, we found a novel transcript of the Tcf-4 gene which contained a segment of 73 bp in front of the (A)9 repeat of the Tcf-4 coding sequence. Sequencing analysis revealed that the inserted fragment was 60% homologous to that of exon IXA of the Tcf-1 gene. It is of interest that this insertion resulted in truncation of Tcf-4, similar to the 1-bp deletion in the (A)9 repeat. Therefore, in part of the Japanese colorectal tumors with MSI, frameshift mutations in Tcf-4 may be of functional significance. Functional alterations in the Tcf-4 signaling network in gastrointestinal tumorigenesis require further investigations., (Copyright 2001 S. Karger AG, Basel)
- Published
- 2001
- Full Text
- View/download PDF
30. Glycogen storage disease type Ia: molecular diagnosis of 51 Japanese patients and characterization of splicing mutations by analysis of ectopically transcribed mRNA from lymphoblastoid cells.
- Author
-
Akanuma J, Nishigaki T, Fujii K, Matsubara Y, Inui K, Takahashi K, Kure S, Suzuki Y, Ohura T, Miyabayashi S, Ogawa E, Iinuma K, Okada S, and Narisawa K
- Subjects
- Alleles, Cell Line, Transformed, Exons, Female, Genotype, Humans, Japan, Leukocytes metabolism, Male, Pedigree, Point Mutation, RNA, Messenger metabolism, Reverse Transcriptase Polymerase Chain Reaction, Alternative Splicing, Glucose-6-Phosphatase genetics, Glycogen Storage Disease Type I genetics, Mutation, RNA Splicing
- Abstract
Glycogen storage disease type Ia (GSD-Ia) is an autosomal recessive disorder of glycogen metabolism caused by a deficiency of glucose-6-phosphatase (G6Pase) that is expressed in the liver, kidney, and intestinal mucosa. Clinical manifestations include short stature, hepatomegaly, hypoglycemia, hyperuricemia, and lactic acidemia. To elucidate a spectrum of the G6Pase gene mutations and their frequencies, we analyzed mutations in 51 unrelated Japanese patients with GSD-Ia. The most prevalent mutation was g727t, accounting for 88 of 102 mutant alleles examined, followed by R170X mutation, which accounted for 6 mutant alleles, and R83H mutation which was observed in 3 mutant alleles. In addition, 3 different, novel mutations, IVS1-1g
- Published
- 2000
31. The IVS4 + 4 A to T mutation of the fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients.
- Author
-
Futaki M, Yamashita T, Yagasaki H, Toda T, Yabe M, Kato S, Asano S, and Nakahata T
- Subjects
- Adolescent, Adult, Age of Onset, Alternative Splicing, Asian People genetics, Base Sequence, Child, Europe ethnology, Exons, Family, Fanconi Anemia Complementation Group C Protein, Fanconi Anemia Complementation Group Proteins, Female, Homozygote, Humans, Introns, Japan, Jews genetics, Male, Polymerase Chain Reaction, Cell Cycle Proteins, Congenital Abnormalities genetics, DNA-Binding Proteins, Fanconi Anemia genetics, Nuclear Proteins, Polymorphism, Single-Stranded Conformational, Proteins genetics, Sequence Deletion
- Abstract
Fanconi anemia (FA) is an autosomal recessive disease characterized by congenital anomalies, aplastic anemia, and a susceptibility to leukemia. There are at least 8 complementation groups (A through H). Extensive analyses of the FA group C gene FANCC in Western countries revealed that 10% to 15% of FA patients have mutations of this gene. The most common mutation is IVS4 + 4 A to T (IVS4), a splice mutation in intron 4, which has been found only in patients of Ashkenazi Jewish ancestry. When we screened 29 Japanese patients (20 unrelated patients and 4 families) using polymerase chain reaction-single strand conformation polymorphism, we found 8 unrelated patients homozygous for IVS4. This is apparently the first non-Ashkenazi-Jewish population for whom this mutation has been detected. The Ashkenazi Jewish patients homozygous for IVS4 have a severe phenotype, in comparison with other FA patients. Our analyses of Japanese patients indicate no significant difference between IVS4 homozygotes and other patients with regard to severity of a clinical phenotype. Thus, ethnic background may have a significant effect on a clinical phenotype in FA patients carrying the same mutation. (Blood. 2000;95:1493-1498)
- Published
- 2000
32. Novel mutations of the FANCG gene causing alternative splicing in Japanese Fanconi anemia.
- Author
-
Yamada T, Tachibana A, Shimizu T, Mugishima H, Okubo M, and Sasaki MS
- Subjects
- Amino Acid Substitution, DNA Mutational Analysis, Family Health, Fanconi Anemia Complementation Group G Protein, Humans, Japan, Pedigree, Alternative Splicing, DNA-Binding Proteins genetics, Fanconi Anemia genetics, Mutation
- Abstract
Fanconi anemia (FA), an autosomal recessive disorder characterized by a progressive pancytopenia associated with congenital anomalies and high predisposition to malignancies, is a genetically and clinically heterogeneous disease. At least eight complementation groups (FA-A to FA-H) have been identified. Previously, we studied mutations of the FANCA gene, responsible for FA-A, and found pathogenic mutations in 12 of 15 unclassified Japanese FA patients. Here, we further studied an additional 5 FA patients for sequence alterations of the FANCA gene and found pathogenic mutations in 2 of them. We further analyzed mutations of the FANCC and FANCG genes, responsible for FA-C and FA-G, respectively, in the remaining 6 FA patients. Although there was no alterations in the FANCC gene in these 6 patients, two novel mutations of the FANCG gene, causing aberrant RNA splicing, were detected in 2 FA patients. One was a base substitution from G to C of the invariant GT dinucleotides at the splice donor site of intron 3, resulting in the skipping of exon 3, as well as the skipping of exons 3 and 4. The other was a base substitution from C to T in exon 8, creating a nonsense codon (Q356X). This mutation resulted in the exclusion of a sequence of 18 nucleotides containing the mutation from the mRNA, without affecting the splicing potential of either the authentic or the cryptic splice donor site. Collectively, 14 of the 20 unclassified Japanese FA patients belong to the FA-A group, 2 belong to the FA-G group, and none belongs to the FA-C group.
- Published
- 2000
- Full Text
- View/download PDF
33. Mutations of calpain 3 gene in patients with sporadic limb-girdle muscular dystrophy in Japan.
- Author
-
Minami N, Nishino I, Kobayashi O, Ikezoe K, Goto Y, and Nonaka I
- Subjects
- Adolescent, Adult, Alleles, Alternative Splicing, Amino Acid Substitution genetics, Blotting, Southern, Blotting, Western, Calpain biosynthesis, Child, DNA Mutational Analysis, Dystrophin biosynthesis, Exons genetics, Female, Humans, Immunohistochemistry, Isoenzymes genetics, Japan, Male, Middle Aged, Muscular Dystrophies diagnosis, Muscular Dystrophies enzymology, Peptide Fragments biosynthesis, Reverse Transcriptase Polymerase Chain Reaction, Calpain genetics, Muscle Proteins, Muscular Dystrophies genetics, Mutation, Missense, Peptide Fragments genetics
- Abstract
Mutations of the calpain 3 gene, an intracellular calcium-activated neutral protease, is one of the causes of limb-girdle muscular dystrophy (LGMD). We examined 14 Japanese patients with sporadic LGMD for calpain 3 mutations, and found four mutations in five patients. Three (R461C, D707G and R147P) were novel missense mutations, and one was a splice-site mutation (801+1g-->a) resulting in skipping of exons 4 and 5. Of the five patients, three patients with homozygous missense mutations showed later onset and slower progression than the other two patients with an exon skipping or mRNA loss of unknown cause. It would appear that the occurrence of calpain 3 gene mutations in sporadic LGMD in Japan may be quite high since all five patients with mutations in this gene were among the 14 patients without apparent family history, an incidence of 36%. These findings also suggest that calpain 3 deficiency occurs in both sporadic and familial LGMD and that direct analysis of the calpain 3 gene may be useful in the definitive diagnosis not only of the 15q-linked familial but also of sporadic cases of LGMD.
- Published
- 1999
- Full Text
- View/download PDF
34. NPC1 gene mutations in Japanese patients with Niemann-Pick disease type C.
- Author
-
Yamamoto T, Nanba E, Ninomiya H, Higaki K, Taniguchi M, Zhang H, Akaboshi S, Watanabe Y, Takeshima T, Inui K, Okada S, Tanaka A, Sakuragawa N, Millat G, Vanier MT, Morris JA, Pentchev PG, and Ohno K
- Subjects
- Adolescent, Adult, Age of Onset, Alternative Splicing, Blotting, Southern, Cell Line, Child, Child, Preschool, DNA, Complementary analysis, Exons, Female, Gene Deletion, Genotype, Humans, Intracellular Signaling Peptides and Proteins, Japan, Male, Models, Genetic, Mutation, Missense, Niemann-Pick C1 Protein, Phenotype, Point Mutation, Polymorphism, Genetic, Polymorphism, Single-Stranded Conformational, Reverse Transcriptase Polymerase Chain Reaction, Carrier Proteins, Membrane Glycoproteins, Mutation, Niemann-Pick Diseases genetics, Proteins genetics
- Abstract
Complementary and genomic DNAs isolated from the fibroblasts of 10 Japanese (7 late infantile, 2 juvenile, and 1 adult form of the disease) and one Caucasian patient with Niemann-Pick disease type C were analyzed for mutations in the NPC1 gene. Fourteen novel mutations were found including small deletions and point mutations. A one-base deletion and a point mutation caused splicing errors. The mutations were not clustered in any particular region of the gene and were found both in and out of the transmembrane domains. Three patients were homozygous, five were compound heterozygous, and the remaining three were suspected of being compound hetrozygous with an unknown error in one of their NPC1 alleles. Of the 14 mutations, the G1553A substitution that caused a splicing error of exon 9 appeared to be relatively common in Japanese patients, because two patients were homozygous and one patient was compound heterozygous for this mutation.
- Published
- 1999
- Full Text
- View/download PDF
35. Organization and partial sequence of the hepatocyte nuclear factor-4 alpha/MODY1 gene and identification of a missense mutation, R127W, in a Japanese family with MODY.
- Author
-
Furuta H, Iwasaki N, Oda N, Hinokio Y, Horikawa Y, Yamagata K, Yano N, Sugahiro J, Ogata M, Ohgawara H, Omori Y, Iwamoto Y, and Bell GI
- Subjects
- Alternative Splicing, Animals, Base Sequence, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Female, Hepatocyte Nuclear Factor 4, Humans, Islets of Langerhans chemistry, Japan, Male, Mice, Molecular Sequence Data, Pedigree, Polymorphism, Restriction Fragment Length, Promoter Regions, Genetic, RNA, Messenger analysis, RNA, Messenger genetics, Sequence Homology, DNA chemistry, DNA-Binding Proteins, Mutation, Phosphoproteins genetics, Transcription Factors genetics
- Abstract
Hepatocyte nuclear factor-4 alpha (HNF-4 alpha) is a member of the nuclear receptor superfamily, a class of ligand-activated transcription factors. A nonsense mutation in the gene encoding this transcription factor was recently found in a white family with one form of maturity-onset diabetes of the young, MODY1. Here, we report the exon-intron organization and partial sequence of the human HNF-4 alpha gene. In addition, we have screened the 12 exons, flanking introns and minimal promoter region for mutations in a group of 57 unrelated Japanese subjects with early-onset NIDDM/MODY of unknown cause. Eight nucleotide substitutions were noted, of which one resulted in the mutation of a conserved arginine residue, Arg127 (CGG)-->Trp (TGG) (designated R127W), located in the T-box, a region of the protein that may play a role in HNF-4 alpha dimerization and DNA binding. This mutation was not found in 214 unrelated nondiabetic subjects (53 Japanese, 53 Chinese, 51 white, and 57 African-American). The R127W mutation was only present in three of five diabetic members in this family, indicating that it is not the only cause of diabetes in this family. The remaining seven nucleotide substitutions were located in the proximal promoter region and introns. They are not predicted to affect the transcription of the gene or mRNA processing and represent polymorphisms and rare variants. The results suggest that mutations in the HNF-4 alpha gene may cause early-onset NIDDM/MODY in Japanese but they are less common than mutations in the HNF-1 alpha/MODY3 gene. The information on the sequence of the HNF-4 alpha gene and its promoter region will facilitate the search for mutations in other populations and studies of the role of this gene in determining normal pancreatic beta-cell function.
- Published
- 1997
- Full Text
- View/download PDF
36. The ornithine transcarbamylase (OTC) gene: mutations in 50 Japanese families with OTC deficiency.
- Author
-
Matsuda I and Tanase S
- Subjects
- Alternative Splicing, Female, Gene Frequency, Humans, Infant, Newborn, Japan, Male, Ornithine Carbamoyltransferase chemistry, Point Mutation, Protein Structure, Secondary, Sequence Deletion, X Chromosome, Mutation, Ornithine Carbamoyltransferase genetics, Ornithine Carbamoyltransferase Deficiency Disease
- Abstract
Mutations in the OTC gene in 50 Japanese families with OTC deficiency were reviewed in relation to the phenotype of the patients and predicted structure of the mutant enzyme. Similar to other X-linked diseases, mutant alleles in OTC deficiency are highly heterogeneous. Mutations observed in male patients with neonatal onset of the disease included base insertion/deletion, exon skipping, and nonsense and missense mutations in exon 4, 5, 6, or 7. OTC activity was essentially undetectable in this group of patients. These mutations possibly resulted in unstable mRNA or truncated protein, or involved the active site or core domain of the enzyme leading to structural changes. In male patients with late onset, abnormalities observed were missense mutations in exons 2, 4, 8, 9, and 10, and missense mutations plus donor site errors involving exons 4, 5, and 6. OTC activity in these patients was 8.1 +/- 6.3% of the control and most mutations occurred on the surface of the protein. In female patients, age at onset ranged from 19 months to 7 years, depending on residual OTC activities (4.5 to 33% of the control). Most mutations in this group were similar to those seen in male patients with neonatal onset, i.e., nonsense and missense mutations in exons 5 and 6, and exon skipping, leading to null enzyme activity. These collective data can serve for genetic counseling and monitoring in prenatal care.
- Published
- 1997
37. Skipping of exon 14 and possible instability of both the mRNA and the resultant truncated protein underlie a common cholesteryl ester transfer protein deficiency in Japan.
- Author
-
Gotoda T, Kinoshita M, Ishibashi S, Inaba T, Harada K, Shimada M, Osuga J, Teramoto T, Yazaki Y, and Yamada N
- Subjects
- Alternative Splicing, Amino Acid Sequence, Animals, COS Cells, Carrier Proteins metabolism, Cholesterol Ester Transfer Proteins, Heterozygote, Humans, Introns, Japan ethnology, Lipid Metabolism, Inborn Errors metabolism, Molecular Sequence Data, RNA, Messenger metabolism, Structure-Activity Relationship, Carrier Proteins genetics, Cholesterol Esters metabolism, Glycoproteins, Lipid Metabolism, Inborn Errors genetics
- Abstract
Among the Japanese population, a G-to-A mutation at the beginning of intron 14 of the human cholesteryl ester transfer protein (CETP) gene is a frequent cause of CETP deficiency characterized by markedly increased HDL cholesterol. The resulting abnormalities responsible for null CETP deficiency were studied in detail. The CETP mRNA transcripts amplified by polymerase chain reaction from the monocyte-derived macrophages of two homozygous patients were both found to be normal except for the whole deletion of exon 14. The deletion causes a shift of reading frame and introduces a premature termination codon downstream. Examination of the macrophage RNA from heterozygotes suggested the increased instability of the abnormal mRNA in the cytoplasm, because the amount of the aberrant transcript was nearly one third that of a normal transcript in the cytoplasm, while they were equal in the nucleus. Although this indicated the synthesis of a mutant CETP that lacks about 15% at its carboxy terminus, immunoblot analysis demonstrated that the abnormal CETP was virtually absent in both the media and cell lysates of transfected COS-1 cells, which massively expressed the mutant CETP mRNA. These results elucidate the primary abnormality due to the common CETP splicing mutation to be the exon skipping of mRNA, which decreases the level of mRNA and produces a truncated protein that should be rapidly degraded intracellularly.
- Published
- 1997
- Full Text
- View/download PDF
38. A human pancreatic islet inwardly rectifying potassium channel: cDNA cloning, determination of the genomic structure and genetic variations in Japanese NIDDM patients.
- Author
-
Tanizawa Y, Matsubara A, Ueda K, Katagiri H, Kuwano A, Ferrer J, Permutt MA, and Oka Y
- Subjects
- Alternative Splicing, Amino Acid Sequence, Base Sequence, Blotting, Northern, Chromosome Mapping, Cloning, Molecular, DNA Primers, Exons, Female, G Protein-Coupled Inwardly-Rectifying Potassium Channels, Humans, In Situ Hybridization, Fluorescence, Japan, Lymphocytes physiology, Molecular Sequence Data, Point Mutation, Polymerase Chain Reaction, Polymorphism, Single-Stranded Conformational, Transcription, Genetic, Chromosomes, Human, Pair 21, Diabetes Mellitus, Type 1 genetics, Diabetes Mellitus, Type 1 physiopathology, Genetic Variation, Islets of Langerhans physiopathology, Potassium Channels biosynthesis, Potassium Channels genetics, Potassium Channels, Inwardly Rectifying
- Abstract
Ligand gated potassium channels, such as the ATP-regulated potassium channel, play crucial roles in coupling of stimuli to insulin secretion in pancreatic beta cells. Mutations in the genes might lead to the insulin secretory defects observed in patients with non-insulin-dependent diabetes mellitus (NIDDM). We isolated a cDNA encoding a putative subunit of a ligand gated potassium channel from a human islet cDNA library. The channel, which we designated hiGIRK2, appeared to be an alternative spliced variant and a human homologue of recently reported mbGIRK2, KATP-2/BIR1. Transcripts were detected in human brain and pancreas, but not in other tissues including cardiac muscle. The sizes of transcripts in the pancreas differed from those in the brain, suggesting tissue-specific alternative splicing and possible isoforms. We then isolated human genomic clones, determined the complete genomic structure and localized the gene to chromosome 21 (21q22). The gene was comprised of four exons and the protein was encoded by three exons. The entire coding region of the hiGIRK2 gene was scanned by polymerase chain reaction-single strand conformation polymorphism analysis in 80 Japanese NIDDM patients. We found five nucleotide substitutions; three were silent mutations of the third base of codons, one in the first intron, 9 bases upstream of exon 2, and one in the 3'-untranslated region. We conclude that mutations in the gene encoding hiGIRK2, a (subunit of) ligand gated potassium channel, is not a major determinant of the susceptibility to NIDDM in Japanese.
- Published
- 1996
- Full Text
- View/download PDF
39. Higher expression levels of alternatively spliced pX mRNA in human T lymphotropic virus type I asymptomatic carriers positive for antibodies to p40tax protein.
- Author
-
Hirata M, Ikematsu H, Nakashima K, Hayashi J, and Kashiwagi S
- Subjects
- Aged, Aged, 80 and over, Base Sequence, Cloning, Molecular, DNA, Complementary genetics, DNA, Viral blood, Female, Gene Products, tax immunology, HTLV-I Infections epidemiology, HTLV-I Infections immunology, Humans, Japan epidemiology, Lymphocytes virology, Male, Middle Aged, Molecular Sequence Data, Proviruses isolation & purification, RNA, Messenger blood, Sequence Analysis, DNA, Viral Regulatory and Accessory Proteins, Alternative Splicing, Carrier State, HTLV-I Antibodies blood, HTLV-I Infections blood, Retroviridae Proteins, Oncogenic genetics, Transcription Factors
- Abstract
cDNA of human T lymphotropic virus type I (HTLV-I) pX gene mRNA expressed in peripheral blood lymphocytes of asymptomatic carriers was sequenced. One cDNA clone contained a novel splicing acceptor site, indicating an unidentified form of pX mRNA: pX delta 17 delta 37. All 21 asymptomatic carriers expressed some level of alternatively spliced pX mRNA (pX, pX delta 17, p21rex, orfII, or pX delta 17 delta 37). pX and pX delta 17 were the dominant mRNA species among the five pX mRNAs. All pX mRNAs but orfII correlated significantly with amounts of provirus DNA (P < .05). Levels of provirus DNA and pX mRNAs were significantly higher in anti-p40tax-positive carriers than in negative ones. These observations suggest that the pX mRNAs are expressed ubiquitously, with a complex pattern of splicing, and that the presence of anti-p40tax may serve as a marker for a higher virus load and viral replication levels in asymptomatic HTLV-I carriers.
- Published
- 1995
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.